Literature DB >> 30779834

Understanding the role of echocardiography in remodeling after acute myocardial infarction and development of heart failure with preserved ejection fraction.

Raluca Tomoaia1, Ruxandra Stefana Beyer2, Gelu Simu3, Adela Mihaela Serban4, Dana Pop5.   

Abstract

Despite the use of reperfusion therapies in the last decades, acute myocardial infarction further remains one of the most frequent causes of mortality. This is mainly caused by changes in the ventricular architecture leading to ventricular remodeling, followed by progressive development of heart failure. Transthoracic echocardiography is a non-invasive instrument which can provide information about the extent of the ischemic process and its consequences but can also predict the outcomes after myocardial infarction. Although standard echocardiographic parameters are currently used for risk stratification of these patients, they might not truly reflect left ventricular systolic dysfunction in acute myocardial infarct patients, since the detection of subtle changes in the myocardial function is beyond their limits. The aim of this review is to underline the use of advanced echocardiographic parameters in identifying patients at risk for developing post-acute myocardial infarction heart failure and subsequent adverse events. Advanced echocardiographic parameters derived from speckle tracking echocardiography provide a detailed assessment on the global and regional left ventricular deformation. Therefore, speckle tracking echocardiography has a major role in predicting the prognosis of acute myocardial infarction patients and particularly in the development ofsubsequent heart failure, which might be prevented with early initiation of adequate therapy.

Entities:  

Mesh:

Year:  2019        PMID: 30779834     DOI: 10.11152/mu-1768

Source DB:  PubMed          Journal:  Med Ultrason        ISSN: 1844-4172            Impact factor:   1.611


  6 in total

1.  CATAN: Chart-aware temporal attention network for adverse outcome prediction.

Authors:  Zelalem Gero; Joyce C Ho
Journal:  IEEE Int Conf Healthc Inform       Date:  2021-10-15

2.  Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure.

Authors:  Yingdong Lu; Mi Xiang; Laiyun Xin; Yang Zhang; Yuling Wang; Zihuan Shen; Li Li; Xiangning Cui
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

3.  The Use of Artificial Hypoxia in Endurance Training in Patients after Myocardial Infarction.

Authors:  Agata Nowak-Lis; Tomasz Gabryś; Zbigniew Nowak; Paweł Jastrzębski; Urszula Szmatlan-Gabryś; Anna Konarska; Dominika Grzybowska-Ganszczyk; Anna Pilis
Journal:  Int J Environ Res Public Health       Date:  2021-02-09       Impact factor: 3.390

4.  Comprehensive Assessment of the Left Ventricular Systolic Function in the Elderly with Acute Myocardial Infarction Using Echocardiography.

Authors:  Xin Huang; Yuan Liu; Bo Guan; Wenyi Yang; Shasha Sun; Jiakun Luo; Yukun Luo; Jian Cao; Yujiao Deng
Journal:  Int J Gen Med       Date:  2022-02-11

5.  3-iodothyronamine inhibits apoptosis induced by myocardial ischemia reperfusion via the Akt/FoxO1 signaling pathway.

Authors:  Haiyan Zhou; Lili Mo; Niwen Huang; Changchao Zou; Chao Li; Muzhi Lin; Bei Zhang; Bo Wei; Ping Li; Xiaoyun Si; Jingjing Chen; Wei Li; Xingde Liu; Bailong Hu
Journal:  Ann Transl Med       Date:  2022-02

6.  Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats.

Authors:  Rong-Hua Zheng; Xiao-Jie Bai; Wei-Wei Zhang; Jing Wang; Feng Bai; Cai-Ping Yan; Erskine A James; Himangshu S Bose; Ning-Ping Wang; Zhi-Qing Zhao
Journal:  Drug Des Devel Ther       Date:  2019-08-06       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.